ArticleBioengineering & translational medicine2026
ROS-responsive robust hydrogels based on thiol-ene click chemistry for enhancing the healing of infected wounds.
Article in Bioengineering & translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of novel antimicrobial wound healing dressings has become an urgent challenge with the increasing prevalence of drug-resistant bacterial infections. Herein, a reactive oxygen species (ROS) responsive robust hydrogel (THMA/TCMC-Gel@Cur) based on "thiol-ene" click chemistry was developed for infected wounds. The addition of curcumin-loaded gelatin nanoparticles (Gel@Cur) imparted excellent antibacterial and antioxidant properties to the THMA/TCMC-Gel@Cur hydrogel. Thiols and alkenes quickly formed thioether bonds through the "thiol-ene" click chemical reaction. The hydrophobic thioether bonds could be oxidized to hydrophilic sulfoxide bonds by ROS. THMA/TCMC-Gel@Cur hydrogel formed by "thiol-ene" click chemistry could respond to ROS and increase water molecules to enter the interior of the hydrogel by switching the hydrophilic to hydrophobic characteristics, thereby accelerating drug diffusion in the porous network. In vivo results showed that wounds treated with THMA/TCMC-Gel@Cur hydrogel had a wound closure ratio of 93.56% within 14 days, which was significantly higher than the other treatment groups. The THMA/TCMC-Gel@Cur hydrogel exhibited significant potential for clinical application, poised to enhance the quality of life for patients suffering from infectious dermatological disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.